INTRODUCTION
Acute pancreatitis is a potentially fatal disease cha racterized by wide clinical variation, ranging from a mild selflimiting to severe disease complicated with sepsis and multiple organ failure, leading to high morbidity and mortality [1] . Severe acute pancreatitis (SAP) develops in 10%25% of the patients, which is also a systemic disease and usually induces injury to extrapancreatic organs, such as lung, liver and kidney, leading to multiple organ failure and even death [2, 3] . Acute lung injury (ALI) is a common and serious complication of SAP. It can develop into acute respiratory distress syndrome (ARDS) without timely intervention [4, 5] . At present, the early diagnosis of SAP associated with ALI is still difficult. Some biochemical parameters, such as highmobility group box (HMGB)1, preB cell colonyenhancing factor (PBEF) and surfactant protein (SP)A, have been used for diagnosis of ALI [69] . However, there are few research studies in this area and there are no definitive diagnostic markers; additionally, sometimes the concentration of the markers can be affected by other factors. So, it is important to choose several biomarkers that might be used jointly to improve the diagnostic rate and establish the mechanism of SAP associated with ALI. Micro (mi)RNAs are a family of naturally occurring, small noncoding RNA molecules that play an important regulatory role in gene expression. They are involved in numerous pathophysiological processes within cells and represent major regulators of gene expression by virtue of their preponderance to target transcription factors. miRNAs have been proposed as ideal biomarkers of disease, including diagnosis, prognosis and monitoring of treatment responses. Circulating miRNAs, presenting in a stable form protected from endogenous RNase activation, are highly stable in blood serum. Hence, in view of their potential use as novel, noninvasive biomarkers, the profiles of circulating miRNAs have been explored in diseases such as cancer, heart failure, myocardial infarction and spinal cord injury [1017] . miRNA analysis of plasma from patients with SAP associated with ALI might yield new biomarkers for diagnosis and identify potential treatment targets for ALI [18, 19] . The present study was designed to test the hypo theses that circulating miRNAs are closely related to the incidence of SAP associated with ALI, they are be involved in a variety of pathophysiological processes of ALI, and can be used as a circulating marker to predict the disease. This study aimed to identify expression of the different circulating miRNAs and their target genes in patients with SAP associated with ALI, and in those with SAP without ALI. The findings from this study will contribute to early diagnosis and treatment of SAP associated with ALI.
MATERIALS AND METHODS

Patients
All patients with SAP were admitted within 72 h after onset of symptoms to the Medical or Surgical Intensive Care Units of the Affiliated Zhongshan Hospital of Dalian University and Nanjing General Hospital of Nanjing Military Command from January 2010 to December 2013. Twelve of 30 SAP patients were not complicated with ALI. All patients met the criteria of the Atlanta definition of SAP. Specifically, SAP diagnosis should meet at least one of the following criteria: (1) APACHE Ⅱ score ≥ 8; (2) Ranson score ≥ 3; (3) organ failure (i.e. transient and persistent); and (4) local complications (i.e. necrosis, abscess or pseudocyst). To ensure inclusion of only eligible patients with a first attack of SAP, patients with recurrent SAP, chronic pancreatitis or pancreatic cancer were excluded. ALI was defined by the American European Consensus Conference [20] . Patient demographic and clinical characteristics are summarized in Table 1 . Six SAP patients were finally excluded for not meeting all inclusion criteria, and 24 patients met the criteria; six of 24 serum samples of patients were randomly selected for miRNA microarray analysis. This study was approved by the Ethics Committee of the Affiliated Zhongshan Hospital of Dalian University and Nanjing General Hospital of Nanjing Military Command. All of the patients gave written informed consent.
Serum samples and RNA isolation
Fourmilliliter serum specimens from each patient were collected immediately after grouping of patients into SAP without ALI and SAP with ALI. Serum samples were immediately frozen in liquid nitrogen and then stored at 80 ℃ for later determination. Total RNA was extracted from serum specimens using a mirVana PARIS kit (Ambion, Austin, TX, United States). The quantity and quality of total RNA were determined using an ultraviolet spectrophotometer at 260 and 280 nm. miRNA microarray analysis miRNA microarrays were manufactured by Agilent Technologies (Santa Clara, CA, United States). Total RNA samples (48 µg) were 3'extended with a poly(A) tail using poly(A) polymerase. An oligonucleotide tag was then ligated to the poly(A) tail for later fluorescent dye staining (Atactic Technologies, Houston, TX, United States) [2123] . Similar methods reported in a previous work were used in this section [24, 25] . All raw data were transformed to log 2 values, and each expression was normalized by having zero mean and unit sample variance. In order to screen significantly differentially expressed miRNAs, we compared expression in serum between the patients with SAP with ALI and those with SAP without ALI. The relative miRNA expression levels were further normalized using the overall median value for patients with SAP with ALI, which gave each patient a median log ratio of 0 for normalized expression levels. The weighted differences in miRNA expression between patients with SAP with ALI and those with SAP without ALI were calculated using the random variance model ttest, in which foldchange > 1.5 was considered significant. The heatmap analysis and hierarchical cluster analysis of data were performed using Multi Experiment Viewer (MeV) v4.7.1 from the TM4 software package available as opensource software at http://www.tm4.org [26] . Hierarchical clustering was performed using the Euclidean distance metric with complete linkage option.
Verification of miRNA expression by quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
qRTPCR was used to verify miRNA expression identified by microarray analysis. Of 24 serum samples of patients, 18 were assessed by qRTPCR. The primers for RTPCR were used to amplify miRNAs, and were designed using Premier 5.0.RNase inhibitor (Toyobo, Osaka, Japan). The reverse primer, M-MLV reverse transcriptase and U6B were purchased from Guangzhou RiboBio Co. Ltd. (China), and U6B was used as internal control. Mixtures of 1 μg total RNA, 50 nmol/L reverse primer, 5 U MMLV reverse transcriptase (Toyobo), 2 U RNase inhibitor (Toyobo) and 0.5 μmol/L dNTP were incubated for 30 min at 16 ℃, 30 min at 42 ℃, and 15 min at 70 ℃. The reaction mixtures were used as templates for qRT-PCR. PCR product amplification was determined by the level of fluorescence emitted by SYBR Green Realtime PCR Master MixPlus (Takara, Dalian, China) and MX3000P qPCR system (Stratagene, Santa Clara, CA, United States). The PCR mixture, containing 1 μL reverse transcriptase product of total RNA, 10 μL SYBRGreen Realtime PCR Master Mix plus, 2 μL Plus solution, 2 μL each specific forward and reverse primer, and 3 μL diethyl pyrocarbonate water, was prepared in a total final volume of 20 μL. The reaction was performed at 95 ℃ for 2 min, followed by 40 cycles at 95 ℃ for 15 s and 60 ℃ for 1 min. Each sample was run in triplicate. Melting curves were used to verify the specificity of each PCR. The procedure for qRTPCR was described previously [27] .
miRNA target prediction, gene ontology (GO) and pathway network analysis
The putative target prediction of validated miRNAs by qRTPCR was performed using three online software programs: PicTar: http://www.pictar.org/; miRanda: http://www.microrna.org/microrna/home. do/; and TargetScan: http://www.targetscan.org. We used PicTar, miRanda and TargetScan together to enhance the credibility of the study. PicTar identi fied a list of putative targets, searching for almost 
Statistical analysis
Statistical analyses were performed using GraphPad Prism 6.0 software (San Diego, CA, United States).
Fisher's exact test and ttest were used to assess differences in clinical features between the participants in the two groups. A value of P < 0.05 was considered statistically significant.
RESULTS
Differential expression of miRNAs in patients with SAP with ALI and SAP without ALI
We investigated 287 miRNAs based on microarray data analysis. The miRNAs with foldchanges > 1.5 or < 1/2 and P < 0.05 were selected for further study. Twelve miRNAs met these criteria and were differentially expressed in patients with SAP with ALI, and in those with SAP without ALI. The 12 miRNAs are summarized in Figure 1 .
Validation of differentially expressed miRNAs by qRT-PCR
In order to validate the microarray results, qRTPCR was performed for the identified 12 miRNAs (P < 0.05). We found that five miRNAs (hsamiR223p, hsa miR1260b, hsamiR762, hsamiR23b and hsamiR 23a) were significantly up-regulated and seven (hsamiR550a*, hsamiR3245p, hsamiR484, hsamiR 3313p, hsamiR1403p, hsamiR3423p and hsa miR150) were downregulated in patients with SAP with ALI and in those with SAP without ALI (Figure 2 ).
Analysis of miRNA target genes
Eightyfive putative target genes of the 12 validated miRNAs were found in patients with SAP with ALI and those with SAP without ALI by TargetScan, miRanda and PicTar database.
GO analysis
GO analysis showed annotation of the genes from three ontologies: BP, MF and CC. GO enrichment analysis of 12 validated miRNAs indicated that 4817 GOs were regulated by the down-regulated miRNAs, whereas 5088 GOs were regulated by the upregulated miRNAs. In BP terms, they were enriched in signal transduction and metabolic processes. In CC terms, they focused on cytoplasm, cell membranes and plasma membranes, and were enriched in protein binding and in receptor activity terms in MF ( Figure 3 ).
KEGG pathway enrichment analysis and miRNA-KEGG network
KEGG pathway analysis showed that the target genes of upregulated miRNAs were involved in glutathione metabolism, Wnt signaling pathway, cytokinecytokine receptor interaction, complement and coagulation cascades, methionine metabolism, apoptosis, cytosolic fully complementary sites between miRNAs and 3'untranslated region (UTR) mRNAs. The free energy between the binding sites was then calculated and the results were ranked by means of a score obtained using a hidden Markov model (HMM). miRNAs with multiple binding sites were highly scored. The miRanda algorithm searched for target sites on the 3'UTRs of mRNAs. It considered both the binding energy for the duplex stability and the conservation of the target site among different species. The TargetScan algorithm was based on the identification of fully complementary zones between the miRNA seed (nucleotides 28) and 3'UTR mRNA. Starting from those sites, TargetScan searched for larger interactions, ranking the results in three groups according to the length of the matches.
In particular, the presence of an adenine in the first position of the target site was highly scored because of its evolutionary conservation. The prediction followed the rules: (1) perfect match at the seed region (28 nucleotides from the 5' end of miRNA); (2) minimum free energy of the miRNA/target duplex should be smaller than -20 kcal/mol; and (3) total score for miRNA-mRNA pairs should be > 140. GO was performed for analysis of the biological process (BP), cellular component (CC) and molecular function (MF) of miRNA target genes based on the GO database (http://www.geneontology.org/). Fisher's twoside exact test and χ 2 test were used to classify the GO categories, and the false discovery rate (FDR) was calculated to correct the P values. We chose only GOs that had a P value < 0.05 and FDR < 0.05. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed to identify the enriched pathways of miRNA target genes based on the KEGG database (http://www.genome.jp/ kegg/). This analysis provided a better understanding of gene expression information as a complete network. KEGG pathway annotation of the miRNA targets was found using the Database for Annotation, Visualization and Integrated Discovery (DAVID) gene annotation tool (http://david.abcc. ncifcrf.gov/). Fisher's exact test and the threshold of significance were defined by the P value and FDR. The screening criterion was P < 0.05. To calculate the enrichment ratio and P value for KEGG analysis, we defined N as number of genes annotated by pathway chip and M as number of differentially expressed genes annotated by pathway in predicted miRNA targets. We recorded the intersecting genes belonging to GO and the pathway at the same time. According to the attributes of the intersecting target genes and miRNAs, the miRNA gene network, representing the critical miRNAs and their targets, was established in accordance with the miRNA degree. The key miRNA and gene in the network had the largest extent. The most important biological metabolic pathway and signal transduction pathway could be determined using pathway enrichment.
DNAsensing pathway, Notch signaling pathway, chemokine signaling pathway, and mitogenactivated protein kinase (MAPK) signaling pathway. Target genes of downregulated miRNAs were related to the insulin signaling pathway, transforming growth factor (TGF)β signaling pathway, Tcell receptor signaling pathway, amino sugar and nucleotide sugar metabolism, and starch and sucrose metabolism. As an example, the Wnt signaling pathway involved in upregulated miRNAs and regulation of Rab GTPase activity by downregulated miRNAs is shown in Figure 4A and B.
DISCUSSION
In this study, we identified that 12 miRNAs, including five upregulated (hasmiR223p, 1260b, 762, 23b and 23a) and 7 downregulated (hasmiR550a5p, 3245p, 484, 3313p, 223p, 1403p and 3423p) were significantly expressed in patients with SAP with ALI and in those with SAP without ALI. Furthermore, we found that 4817 GOs regulated by the seven downregulated miRNAs and 5088 GOs regulated by the five upregulated miRNAs were involved in SAP with ALI. These miRNAs may be candidate novel biomarkers and were involved in many biological processes of SAP with ALI, such as signal transduction, metabolic processes, cytoplasm, cell membranes, and receptor activity terms. Moreover, the 85 putative target genes were regulated by 12 specific miRNAs, and the Wnt signaling pathway and Rab GTPase activity were important metabolic pathways that were upregulated and downregulated by miRNAs, respectively. miRNAs are short noncoding RNAs involved in posttranscriptional regulation of gene expression. An increasing body of evidence indicates that miRNAs have investigated the potential involvement of miRNAs in ALI or ARDS. Liu et al [28] found that miRNA200c3p is crucial in ALI/ARDS and that the inhibition of miR200c 3p ameliorated the ALI induced by H5N1 virus infection in vivo, indicating a potential therapeutic target. Vaporidi et al [29] investigated pulmonary miRNA pro filing in a mouse model of high tidal volume ventilation (HVTV)induced lung injury and results showed that of the 335 miRNAs examined, the expression of 50 miRNAs increased > 2fold, expression of 15 miRNAs decreased by more than half and the miRNAs with the greatest increase in expression after 4 h of HVT were miR7b, miR189 and miR223, whereas the miRNAs with the greatest decrease in expression were miR503 and miR211. However, circulating miRNAs as biomarkers of SAP with ALI are still unclear.
In our study, 12 circulating miRNAs were differ entially expressed in patients with SAP with ALI and SAP without ALI. Among these, five miRNAs (hsa-miR223p, 1260b, 762, 23b and 23a) were significantly upregulated and seven (hsamiR550a*, 3245p, 484, 3313p, 223p, 1403p and 3423p) were down regulated. qRTPCR was performed to verify the gene expression levels of these regulated circulating miRNA. In the five differentially overexpressed miRNAs, the expression of hsamiR1260b, 23b and 23a showed a foldchange > 5 with P < 0.01, while hsamiR223p and 762 showed only a > 2 but < 5 foldchange < 5 with P < 0.05. Xu et al [30] found that overexpression of miR1260b in nonsmall cell lung cancer (NSCLC) with lymph node metastasis can be regarded as a specific signature for early progression and prognosis of NSCLC. Sarrion et al [31] reported that expression of miR23a
was correlated with pulmonary function, and silencing of miR23a resulted in increased expression of PGC1α, as well as its well-known regulated genes CYC, SOD, NRF2 and HO1 in patients with idiopathic pulmonary arterial hypertension. Begum et al [32] found that over expression of miR23b in H1838 cells significantly increased cell proliferation, while inhibition of miR23b in H1437 and H1944 cell lines significantly reduced cell doubling time. In addition, our miRNA network analysis predicted that these upregulated miRNAs modulate glutathione metabolism, cytokinecytokine receptor interaction, complement and coagulation cascades, methionine metabolism, apoptosis, cytosolic DNA Figure 3 Gene ontology analysis of genes. In BP terms, they were enriched in signal transduction and metabolic processes. In CC terms, they focused on cytoplasm, cell membranes and plasma membranes, and were enriched in protein binding and receptor activity terms in MF. In each ontology, the first at least 10 enriched terms are listed. BP: Biological process; CC: Cellular component; MF: Molecular function.
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hsa-miR-550a-5p sensing pathway, Notch signaling pathway, chemokine signaling pathway, and MAPK signaling pathway. Ell et al [33] found that the miRNA23b/27b/24 cluster promoted breast cancer lung metastasis by targeting the metastasissuppressive gene prosaposin. Thus, these results show that the significantly overexpressed hsamiR1260b, 23a and 23b may be important biomarkers of SAP with ALI. Nevertheless, there is a lack of relevant studies on their role of pathological processes in ALI induced by ASP. Moreover, there is still no report about the reports with hsamiR223p and hsamiR762 and lung diseases. We also identified seven downregulated miRNAs (hsamiR550a*, 3245p, 484, 3313p, 1403p, 3423p and 150) by microarray analysis in patients with SAP with ALI and SAP without ALI. Expression of hsamiR484, 3313p, 3423p and 150 showed a foldchange < 0.5 with P < 0.01. miRNA550a acts as a prometastatic gene and directly targets cytoplasmic polyadenylation element binding pro tein 4 in hepatocellular carcinoma [34] . Moreover, the miR550a5p/RNF43/Wnt signaling axis acts as a Brg1 target for regulating colorectal cancer metastasis, and miR150 likely regulates miR124a expression and thus augments expression of inflammatory mediators in myeKlf2 / macrophages [35, 36] . Cai et al [37] found that miR199a and miR16 were the most significantly downregulated miRNAs in lipopolysaccharideinduced mouse ALI. In our study, miR199a and miR16 expression did not differ between patients with SAP with ALI and those with SAP without ALI. This discrepancy may have been caused by different inducing factors of ALI. In addition, the results of KEGG pathway enrichment analysis and miRNAKEGG network showed that the target genes of downregulated miRNAs were related to the Wnt signaling pathway, insulin signaling pathway, TGFβ signaling pathway, Tcell receptor signaling pathway, and amino sugar and nucleotide sugar metabolism. Previous studies have shown that signaling pathways are involved in the pathogenesis of ALI. Guo et al [38] reported that Wnt3a overrode the effect of P2X7R on Wnt/βcatenin signaling to prevent death of alveolar epithelial type Ⅰ cells and restrict the severity of ALI. Pittet et al [39] reported that TGF beta was a critical mediator of acute lung injury. Mu et al [40] also reported that the TGFβ1/Smad signaling (pSmad 2 and pSmad 3) pathway was an important mechanism in the course of ALI.
In conclusion, we identified 12 significantly ex pressed circulating miRNAs in patients with SAP with ALI. These miRNAs may be specifically involved in the pathological mechanism of SAP with ALI. miRNAs and their target genes, as novel therapeutic targets, look promising. At present, the study regarding the mechanism of miRNAs in ALI remains at its nascent stage. miRNAs and their role of pathological processes in ALI induced by SAP remain to be elucidated. There were some limitations in this study. The main limitation was the small sample size. The results need to be verified in multicenter clinical trials. In addition, the molecular mechanism of circulating miRNAs regulating downstream signaling pathways should be further studied in patients with SAP with ALI.
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